| Ytd | 62.71% | |
| 1y | -53.17% |
| Open | 3.95 | Prev Close | 3.95 | Low | 3.67 | High | 3.95 | Mkt Cap | 369.76M |
| Vol | 2.53M | Avg Vol | 1.58M | EPS | -0.81 | P/E | N/A | Forward P/E | -3.42 |
| Beta | 1.19 | Short Ratio | 3.16 | Inst. Own | 64.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-21 | 50-d Avg | 4.68 | 200-d Avg | 3.90 | 1yr Est | 13.00 |
Shares of Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) have earned a consensus recommendation of
Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoin
Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoi
REDWOOD CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o
Bank of America Corp DE reduced its stake in Rezolute, Inc. (NASDAQ: RZLT) by 31.3% during the undef
Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w
REDWOOD CITY, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis
Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis
Guggenheim analyst Debjit Chattopadhyay maintains Rezolute (NASDAQ:RZLT) with a Buy and raises th
Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate
Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare
REDWOOD CITY, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
Maxim Group analyst Jason McCarthy maintains Rezolute (NASDAQ:RZLT) with a Buy and raises the pri
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY
Citizens analyst Jason N. Butler upgrades Rezolute (NASDAQ:RZLT) from Market Perform to Market Ou
Wedbush analyst Yun Zhong maintains Rezolute (NASDAQ:RZLT) with a Outperform and raises the price
U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock
Rezolute, Inc. (NASDAQ:RZLT) reported an interim update from its ongoing Phase 3 upLIFT study evalua
Rezolute says 6 of 8 patients met the primary endpoint in its Phase 3 upLIFT study of ersodetug for
HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and mai
Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare
Study now 50% enrolled 6 of 8 participants have already met the responder criterion for the study's
REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrat
LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rezolute, Inc., (“Rezol
Oral presentation will include previously announced topline results as well as pre-specified and pos
RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earli
In a recent update, Rezolute shared insights from its March 17 meeting with the FDA regarding its Ph
REDWOOD CITY, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o
ADMA Biologics (NASDAQ: ADMA - Get Free Report) and Rezolute (NASDAQ: RZLT - Get Free Report) are bo
NEW YORK--(BUSINESS WIRE)---- $RZLT #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie
On Wednesday, 311 stocks hit new 52-week lows.
On Monday, 369 companies set new 52-week lows.
During Friday, 125 stocks hit new 52-week lows.
On Thursday, 111 stocks hit new 52-week lows.
On Tuesday, 120 companies set new 52-week lows.
Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: D
Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc.
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares jumped 67.3% to $5.94 after the company a